Kokad Pharmaceutical Laboratories Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 20-12-2024
- Paid Up Capital ₹ 5.97 Cr
as on 20-12-2024
- Company Age 39 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.61 Cr
as on 20-12-2024
- Satisfied Charges ₹ 4.79 Cr
as on 20-12-2024
- Revenue -99.92%
(FY 2022)
- Profit 99.64%
(FY 2022)
- Ebitda 99.87%
(FY 2022)
- Net Worth 99.90%
(FY 2022)
- Total Assets -99.91%
(FY 2022)
About Kokad Pharmaceutical Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 5.97 Cr.
The company currently has active open charges totaling ₹1.61 Cr. The company has closed loans amounting to ₹4.79 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mathew Thomas, Rosamma Mathew, and Ammu Mathew serve as directors at the Company.
- CIN/LLPIN
U24231KL1985PLC004282
- Company No.
004282
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Sep 1985
- Date of AGM
15 Jun 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kottayam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kokad Pharmaceutical Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mathew Thomas  | Whole-Time Director | 02-Sep-1985 | Current |
| Rosamma Mathew | Director | 10-Jun-2005 | Current |
| Ammu Mathew | Director | 22-Sep-2017 | Current |
Financial Performance of Kokad Pharmaceutical Laboratories.
Kokad Pharmaceutical Laboratories Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.92% decrease. The company also saw a substantial improvement in profitability, with a 99.64% increase in profit. The company's net worth Soared by an impressive increase of 99.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kokad Pharmaceutical Laboratories?
In 2021, Kokad Pharmaceutical Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kerala Antibiotics Pvt LtdActive 31 years 5 monthsMathew Thomas and Rosamma Mathew are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Kerala State Financial Enterprises Ltd Creation Date: 18 Aug 2018 | ₹1.61 Cr | Open |
Kerala Financial Corporation Creation Date: 25 Mar 2004 | ₹1.25 Cr | Satisfied |
State Bank Of Travacore Creation Date: 17 Jul 1999 | ₹1.20 Cr | Satisfied |
How Many Employees Work at Kokad Pharmaceutical Laboratories?
Unlock and access historical data on people associated with Kokad Pharmaceutical Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kokad Pharmaceutical Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kokad Pharmaceutical Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
